Search Within

Jason Philip Holland

Formats
  1. Journal Article (24)
  2. Meeting Abstract (6)
  3. Book Section (1)
Groups
  1. Center for Molecular Imaging and Biotechnology (CMIB) (26)
  2. Center for Pancreatic Cancer Research (26)
  3. GSK Faculty (26)
  4. Radiochemistry and Imaging Sciences Service (26)
  5. Radiology, Department of (26)
  6. Department of Medicine (12)

More Groups

People
  1. Jason Lewis (26)
  2. Charles Sawyers (6)
  3. Vadim Divilov (6)
  4. Michael Evans (5)
  5. Alessandro Ruggiero (4)
  6. Samuel Rice (4)

More People

Years
  1. 2015 (1)
  2. 2014 (1)
  3. 2013 (5)
  4. 2012 (2)
  5. 2011 (6)
  6. 2010 (9)

More Years

Publications
  1. Journal of Nuclear Medicine (8)
  2. Journal of Clinical Oncology (2)
  3. Journal of Labelled Compounds and Radiopharmaceuticals (2)
  4. Molecular Imaging (2)
  5. Nuclear Medicine and Biology (2)
  6. Cancer Discovery (1)

More Publications

Publishers
  1. Society of Nuclear Medicine (8)
  2. Royal Society of Chemistry (3)
  3. American Society of Clinical Oncology (2)
  4. Elsevier Science Inc. (2)
  5. Sage Publications, Inc. (2)
  6. Springer (2)

More Publishers

Results (31)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Imaging androgen receptor signaling in prostate cancer with PET
    Meeting Abstract

    Evans, M.; Ulmert, D.; Holland, J.; Doran, M.; Spratt, D.; Sawyers, C.; Lewis, J.
    Journal of Nuclear Medicine (2015)

    Fulltext@MSK | Save
  • 89Zr-huJ591 immuno-PET imaging in patients with advanced metastatic prostate cancer
    Journal Article

    Pandit-Taskar, N.; O'Donoghue, J. A.; Beylergil, V.; Lyashchenko, S.; Ruan, S.; Solomon, S. B.; Durack, J. C.; Carrasquillo, J. A.; Lefkowitz, R. A.; Gonen, M.; more...
    European Journal of Nuclear Medicine and Molecular Imaging (2014)

    Fulltext@MSK | Save
  • Radiopharmaceuticals for imaging in oncology with special emphasis on positron-emitting agents
    Book Section

    Zeglis, B. M.; Holland, J. P.; Lebedev, A. Y.; Cantorias, M. V.; Lewis, J. S.
    In Strauss, H. W.; Mariani, G.; Volterrani, D.; Larson, S. M. (Eds.) Nuclear Oncology: Pathophysiology and Clinical Applications. 1st ed (2013)

    Fulltext@MSK | Save
  • Phase I trial of zirconium 89 (Zr89) radiolabeled J591 in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Morris, M. J.; Pandit-Taskar, N.; Carrasquillo, J. A.; O'Donoghue, J. A.; Humm, J.; Lyashchenko, S. K.; Haupt, E. C.; Bander, N. H.; Tagawa, S. T.; Holland, J. P.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Monitoring afatinib treatment in HER2-positive gastric cancer with (18)F-FDG and (89)Zr-trastuzumab PET
    Journal Article

    Janjigian, Y. Y.; Viola-Villegas, N.; Holland, J. P.; Divilov, V.; Carlin, S. D.; Gomes DaGama, E. M.; Chiosis, G.; Carbonetti, G.; de Stanchina, E.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Annotating oncogene status in castration-resistant prostate cancer with zirconium-89-labeled radiotracers
    Meeting Abstract

    Evans, M. J.; Holland, J. P.; Ulmert, D.; Lewis, J. S.; Sawyers, C. L.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Imaging tumor burden in the brain with (89)Zr-transferrin
    Journal Article

    Evans, M. J.; Holland, J. P.; Rice, S. L.; Doran, M. G.; Cheal, S. M.; Campos, C.; Carlin, S. D.; Mellinghoff, I. K.; Sawyers, C. L.; Lewis, J. S.
    Journal of Nuclear Medicine (2013)

    Fulltext@MSK | Save
  • Annotating MYC status with (89)Zr-transferrin imaging
    Journal Article

    Holland, J. P.; Evans, M. J.; Rice, S. L.; Wongvipat, J.; Sawyers, C. L.; Lewis, J. S.
    Nature Medicine (2012)

    Fulltext@MSK | Save
  • Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen
    Journal Article

    Ulmert, D.; Evans, M. J.; Holland, J. P.; Rice, S. L.; Wongvipat, J.; Pettersson, K.; Abrahamsson, P. A.; Scardino, P. T.; Larson, S. M.; Lilja, H.; more...
    Cancer Discovery (2012)

    Fulltext@MSK | Save
  • Positron emission tomography (PET) with (89)Zr-labeled trastuzumab ((89)Zr-trastuzumab): Monitoring HER2 expression in HER2-positive gastric cancer in vivo
    Meeting Abstract

    Janjigian, Y. Y.; Villegas, N. T.; Holland, J. P.; Shah, M. A.; Divilov, V.; Kelsen, D. P.; Lewis, J. S.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save